Carisma Therapeutics Statistics

Total Valuation

CARM has a market cap or net worth of $16.74 million. The enterprise value is $10.48 million.

Market Cap	16.74M
Enterprise Value	10.48M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CARM has 41.79 million shares outstanding. The number of shares has increased by 2.72% in one year.

Current Share Class	41.79M
Shares Outstanding	41.79M
Shares Change (YoY)	+2.72%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	11.99%
Owned by Institutions (%)	22.28%
Float	31.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.84
Forward PS	1.46
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.34

Current Ratio	1.34
Quick Ratio	0.82
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-69.64%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-908.15%
Revenue Per Employee	$434,000
Profits Per Employee	-$1.10M
Employee Count	46
Asset Turnover	0.44
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.16% in the last 52 weeks. The beta is 2.79, so CARM's price volatility has been higher than the market average.

Beta (5Y)	2.79
52-Week Price Change	-67.16%
50-Day Moving Average	0.28
200-Day Moving Average	0.55
Relative Strength Index (RSI)	51.68
Average Volume (20 Days)	42,075,299

Short Selling Information

The latest short interest is 3.10 million, so 7.43% of the outstanding shares have been sold short.

Short Interest	3.10M
Short Previous Month	694,368
Short % of Shares Out	7.43%
Short % of Float	9.93%
Short Ratio (days to cover)	0.09

Income Statement

In the last 12 months, CARM had revenue of $19.96 million and -$50.77 million in losses. Loss per share was -$1.22.

Revenue	19.96M
Gross Profit	-31.40M
Operating Income	-50.00M
Pretax Income	-72.70M
Net Income	-50.77M
EBITDA	-47.68M
EBIT	-50.00M
Loss Per Share	-$1.22

Full Income Statement

Balance Sheet

The company has $8.59 million in cash and $2.33 million in debt, giving a net cash position of $6.26 million or $0.15 per share.

Cash & Cash Equivalents	8.59M
Total Debt	2.33M
Net Cash	6.26M
Net Cash Per Share	$0.15
Equity (Book Value)	-36.66M
Book Value Per Share	-0.88
Working Capital	3.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.56 million and capital expenditures -$106,000, giving a free cash flow of -$47.67 million.

Operating Cash Flow	-47.56M
Capital Expenditures	-106,000
Free Cash Flow	-47.67M
FCF Per Share	-$1.14

Full Cash Flow Statement

Margins

Gross margin is -157.30%, with operating and profit margins of -250.47% and -254.28%.

Gross Margin	-157.30%
Operating Margin	-250.47%
Pretax Margin	-254.28%
Profit Margin	-254.28%
EBITDA Margin	-238.83%
EBIT Margin	-250.47%
FCF Margin	n/a

Dividends & Yields

CARM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.72%
Shareholder Yield	-2.72%
Earnings Yield	-303.25%
FCF Yield	-284.73%

Dividend Details

Analyst Forecast

The average price target for CARM is $0.90, which is 124.66% higher than the current price. The consensus rating is "Hold".

Price Target	$0.90
Price Target Difference	124.66%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-18.01%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARM has an Altman Z-Score of -36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-36
Piotroski F-Score	3